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DOI 10.1016/j.chom.2011.12.002SUMMARY microorganisms can be recognized as foreign and engaged byAutophagy is a cellular degradation process that
can capture and eliminate intracellular microbes by
delivering them to lysosomes for destruction.
However, pathogens have evolved mechanisms to
subvert this process. The intracellular bacterium
Brucella abortus ensures its survival by forming the
Brucella-containing vacuole (BCV), which traffics
from the endocytic compartment to the endoplasmic
reticulum (ER), where the bacterium proliferates.
We show that Brucella replication in the ER is
followed by BCV conversion into a compartment
with autophagic features (aBCV). While Brucella
trafficking to the ER was unaffected in autophagy-
deficient cells, aBCV formation required the auto-
phagy-initiation proteins ULK1, Beclin 1, and
ATG14L and PI3-kinase activity. However, aBCV
formation was independent of the autophagy-elon-
gation proteins ATG5, ATG16L1, ATG4B, ATG7, and
LC3B. Furthermore, aBCVs were required to
complete the intracellular Brucella lifecycle and for
cell-to-cell spreading, demonstrating that Brucella
selectively co-opts autophagy-initiation complexes
to subvert host clearance and promote infection.
INTRODUCTION
Pathogenic microbes with an intracellular lifestyle have evolved
various survival strategies to avoid microbicidal mechanisms
and generate unique intracellular niches for replication and
persistence, by modulating cellular processes. Intracellular
parasites or bacteria typically reside either within a membrane-
bound vacuole, which theymodify through controlledmaturation
of their original phagosome or freely in the cytosol after phagoso-
mal escape. Regardless of their intracellular location, invadingCell Hmacroautophagy (herein referred to as autophagy), an intracel-
lular process of capture and lysosomal degradation of damaged
organelles, protein aggregates, and cytosolic content with
a prominent role in intracellular innate immunity (Levine et al.,
2011). Selective antibacterial autophagy, also called xenophagy,
can either target cytosolic bacteria (Checroun et al., 2006;
Collins et al., 2009; Nakagawa et al., 2004; Ogawa et al., 2005;
Rich et al., 2003) or bacteria in both intact and damaged vacuolar
compartments (Birmingham et al., 2006; Gutierrez et al., 2004)
and deliver them to lysosomes, thereby controlling their intracel-
lular survival and replication.
Autophagy is initiated by the nucleation of an isolation
membrane that elongates to envelop autophagic targets into
a double-membrane vacuole, the autophagosome, which in
turn progressively matures and eventually fuses with lysosomes
to create a degradative autolysosome (Levine et al., 2011). The
membrane dynamics of the autophagic process involve various
protein complexes required for nucleation and elongation of the
autophagosome. Key to the initiation of autophagy is the ULK1
complex, which translocates to subdomains of the endoplasmic
reticulum (ER), where it recruits a class III phosphatidylinositol-3-
kinase (PI3-kinase) complex comprised of the autophagy
proteins VPS34, VPS15, Beclin 1, and Atg14L (Itakura and Miz-
ushima, 2010; Matsunaga et al., 2010; Matsunaga et al., 2009),
which in turn generates phosphatidylinositol-3-phosphate
(PI3P) on omegasomes (Axe et al., 2008) that serve as cradles
for the biogenesis of isolation membranes. Elongation of the
isolationmembrane into an autophagosome involves two ubiqui-
tin-like conjugation pathways, both dependent on the autophagy
protein ATG7, which in aggregate generate the ATG12-ATG5/
ATG16L1 protein complex and phosphatidylethanolamine (PE)-
conjugated ATG8 homolog LC3 (He and Klionsky, 2009). Given
the essential roles of these autophagy protein complexes, deple-
tion of these proteins typically abrogates or severely impairs
autophagy, xenophagic control of intracellular microorganisms
(Birmingham et al., 2006; Levine et al., 2011; Zheng et al.,
2009), and resistance to infection (Zhao et al., 2008), although
some ATG5- and ATG7-independent macroautophagic andost & Microbe 11, 33–45, January 19, 2012 ª2012 Elsevier Inc. 33
Figure 1. Post-ER Replication Translocation of Brucella into an Endosomal Compartment
(A) Representative confocal micrographs of BMMs (left) and HeLa cells (right) infected with DsRedm-expressing B. abortus 2308 (red) and immunostained for
LAMP-1 (green) and calreticulin (blue) at 24, 48, and 72 hr pi. Scale bars represent 10 and 2 mm.
(B) Intracellular growth ofB. abortus strain 2308 in either BMMs (open circles) or HeLa cells (closed circles). Cells were infected and intracellular CFUs enumerated
at 3, 24, 48, and 72 hr pi. Data are shown as means ± SEM from a representative experiment performed in triplicate.
(C) Quantification of late LAMP-1-positive BCV formation at 24, 48, and 72 hr pi in BMMs (open circles) and HeLa cells (closed circles). Data are expressed as
percentage of infected cells containing late LAMP-1-positive BCV and are means ± SD from three independent experiments.
(D) Representative confocal micrographs of BMMs infected with either DsRedm-expressing (Rab7 panel) or GFP-expressing (LysoTracker and dextran panels)
B. abortus 2308 and processed for labeling of Rab7 and LAMP-1 (Rab7), acidic compartments (LysoTracker), or endocytic compartments (dextran). Scale bars
represent 10 and 2 mm.
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Autophagy in the Brucella Intracellular Cyclexenophagic processes have been reported (Collins et al., 2009;
Nishida et al., 2009). Due to its prominent antimicrobial func-
tions, various intracellular pathogens have evolved to protect
themselves against xenophagic capture, including the cytosolic
bacteria Listeria monocytogenes (Birmingham et al., 2007; Yosh-
ikawa et al., 2009) and Shigella flexneri (Ogawa et al., 2005).
Additionally, general autophagy has been invoked in the intracel-
lular trafficking of the vacuolar bacteria Coxiella burnetii (Gutier-
rez et al., 2005), Yersinia pestis and pseudotuberculosis (Moreau
et al., 2010; Pujol et al., 2009), Porphyromonas gingivalis (Dorn
et al., 2001), and Brucella abortus (Pizarro-Cerda´ et al., 1998a).
Bacteria of the genus Brucella are the causative agent of
brucellosis, a worldwide zoonosis with significant health and
economic consequences (Pappas et al., 2005). Essential to the
virulence of these bacteria is their ability to enter, survive, prolif-
erate, and persist within a variety of host cell types, including
professional phagocytes such as macrophages and dendritic
cells (Archambaud et al., 2010; Salcedo et al., 2008). Brucella
has evolved to manipulate intracellular membrane trafficking
processes to foster its survival and growth. After phagocytic
uptake or internalization, Brucella resides within a membrane-
bound compartment, the Brucella-containing vacuole (BCV),
which traffics along the endocytic pathway during the first 8 hr
postinfection (pi) and undergoes limited fusion with the lyso-
somal compartment (Starr et al., 2008). These interactions with
late-endocytic/lysosomal compartments are necessary for
induction of the VirB type IV secretion apparatus (Boschiroli
et al., 2002; Starr et al., 2008), a major virulence factor that trans-
locates effector molecules into the host cell (de Jong et al., 2008;
Marchesini et al., 2011) and probably promotes endosomal BCV
(herein referred to as eBCV) trafficking toward the ER (Celli et al.,
2003; Comerci et al., 2001). BCV trafficking to the ER occurs via
interactions with the transitional ER between 4 and 12 hr pi,
which requires the small GTPases Sar1 (Celli et al., 2005) and
Rab2 (Fugier et al., 2009) and culminates in endosomal to ER
membrane exchange on the BCV (Celli et al., 2003). ER-derived
BCVs are replication-permissive organelles (herein referred to as
rBCVs) that are generated by 12 hr pi (Celli et al., 2003; Comerci
et al., 2001; Pizarro-Cerda´ et al., 1998a; Salcedo et al., 2008).
Brucella replication also requires the ER transmembrane protein
IRE1a (Qin et al., 2008), a sensor of the unfolded protein
response (UPR) upon ER stress that also contributes to auto-
phagy induction (Ogata et al., 2006).
While the Brucella intracellular cycle is well defined from entry
to replication in the ER, with initial rounds of replication achieved
within 12 to 24 hr pi (Arellano-Reynoso et al., 2005; Bellaire et al.,
2005; Celli et al., 2003, 2005; Comerci et al., 2001; Fugier et al.,
2009; Pizarro-Cerda´ et al., 1998b; Salcedo et al., 2008), steps
subsequent to bacterial replication in rBCVs are unknown.
Here, we have examined late stages of the Brucella intracellular
cycle in both macrophages and epitheloid cells. We report
a post-ER replication compartment that is initiated at the ER
and converts rBCVs into vacuoles with autophagic features
in a Beclin1-, ULK-1-, and ATG14L-dependent but ATG5-,(E) Representative confocal micrographs of BMMs infected with B. abortus 2308 e
or treated for 6 hr with 200 nM ATc prior to processing at 24 and 72 hr pi for bact
10 and 2 mm.
See also Figure S1.
Cell HATG16L1-, ATG4B-, ATG7-, and LC3B-independent manner.
Importantly, rBCV conversion into these vacuoles completes
the intracellular cycle of Brucella and promotes cell-to-cell
spread. These findings demonstrate a selective subversion of
autophagy nucleation complexes by a pathogenic bacterium in
favor of an infection process.
RESULTS
Brucella Translocates into Endosomal Vacuoles at Late
Stages of Its Intracellular Cycle
To examine late stages of the Brucella intracellular cycle, we first
monitored intracellular growth of the virulent wild-typeB. abortus
strain 2308 in either C57BL/6J murine bone marrow-derived
macrophages (BMMs) or in the human epithelioid cell line
HeLa. Increasing numbers of viable intracellular bacteria were
recovered during a 72 hr infection period, demonstrating bacte-
rial replication in both cell types (Figure 1B). Confocal immuno-
fluorescence microscopy analysis revealed Brucella already
recognized replication patterns within LAMP-1-negative, Calreti-
culin-positive rBCVs at 24 hr pi (Figure 1A), indicating that
internalized bacteria had generated ER-derived replicative
organelles (rBCVs) at this stage. At 48 hr pi, most infected cells
bore increasing numbers of ER-localized, replicating bacteria.
However, 15% ± 6.5% of infected BMMs contained clusters of
bacteria enclosed within large LAMP-1-positive vacuoles, and
12% ± 7.6% of infected HeLa cells harbored LAMP-1-positive
vacuoles containing either one or more bacteria embedded
within, or at the periphery, of rBCV clusters (Figures 1A and
1C). This compartment was more prevalent by 72 hr pi, where
36% ± 11% and 40% ± 13% of infected BMMs and HeLa cells
contained LAMP-1-positive, calreticulin-negative vacuoles
(Figures 1A and 1C), suggesting that replicating Brucella translo-
cate to a vacuolar compartment that is phenotypically distinct
from ER-derived rBCVs.
Consistently, these late BCVs recruited the late endosomal/
lysosomal GTPase Rab7, were acidified and accumulated fluid
phasemarkers in BMMs (Figure 1D), demonstrating their fusoge-
nocity with late endocytic compartments. To verify that these
large endosomal vacuoles harbored live bacteria, BMMs were
infectedwithB. abortus 2308 expressingGFP under an anhydro-
tetracycline (ATc)-inducible promoter and examined for bacterial
fluorescence upon induction. Like bacteria within either eBCVs
(8h pi; data not shown) or rBCVs (24 hr pi; Figure 1E), those con-
tained within LAMP-1-positive vacuoles at 72 hr pi expressed
GFP upon ATc treatment once these vacuoles were formed (Fig-
ure 1E), demonstrating that they are transcriptionally active, in
agreement with the sustained recovery of viable bacteria after
48 hr pi (Figure 1B).
Controlling secondary infections with a low concentration of
gentamicin (25 mg/ml) from 24 hr pi onward did not affect the
formation of this compartment (Figures S1A and S1B available
online). Therefore these late endosomal vacuoles do not origi-
nate from reinfection events and constitute a post-ER replicationxpressing an anhydrotetracycline (ATc)-inducible GFP that were left untreated
erial and host-cell DNA (red) and LAMP-1 (blue) labeling. Scale bars represent
ost & Microbe 11, 33–45, January 19, 2012 ª2012 Elsevier Inc. 35
Figure 2. Late Endosomal BCVs Display Structural Features of Autophagy, but Do Not Accumulate the Autophagy protein LC3
(A) Representative TEM images of BMMs infected with B. abortus 2308 for 72 hr. Arrows indicate double-membrane structures on BCVs or wrapping around
single membrane BCVs. Inset a shows single-membrane rBCVs. Insets b, c, and d show multimembrane BCVs. Scale bars represent 500 and 200 nm.
(B) Representative confocal micrographs of BMMs (left) or HeLa cells (right) infected with DsRedm-expressing B. abortus 2308 (red) and immunostained for LC3
(green) and LAMP-1 (blue) at 72 hr pi. Scale bars represent 10 mm and 2 mm.
(C) Quantification of late LAMP-1-positive BCVs that accumulated LC3 at 48 and 72 hr pi in BMMs (filled bars) and HeLa cells (open bars). Data are shown as
means ± SD from three independent experiments.
See also Figure S2.
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ysis of these vacuoles revealed that, unlike rBCVs that typically
display single, ribosome-laden membranes, (Figure 2A, inset a)
(Celli et al., 2003)),20%of BCVs at 72 hr pi in BMMs (Figure 4A)
were either engulfed by double-membrane crescents (Figure 2A,
inset b) or delimited by multiple membranes (Figure 2A, inset d,
and Figure 4A), suggestive of an autophagy process. Double
membrane-bound bacterial clusters consistent with large vacu-
oles (Figure 1A) were also detected (Figure 2A, inset c, and
Figure S2) and their endosomal nature was confirmed by immu-
noelectron microscopy in both BMMs and HeLa cells (72 hr pi;
Figure S2B). Taken together, these observations indicate that
after ER replication, endosomal BCVs display structural features
consistent with an autophagic process and were named auto-
phagic BCVs, or aBCVs.
aBCV Formation Requires the Autophagy-Associated
Proteins Beclin1 and ULK1
Given the ultrastructural features of aBCVs, we next examined
whether these vacuoles display markers of autophagic
membranes. Using LAMP-1 as a marker for aBCVs, we did not36 Cell Host & Microbe 11, 33–45, January 19, 2012 ª2012 Elsevier Idetect endogenous LC3 isoforms on these vacuoles in either
BMMs or HeLa cells at 48 or 72 hr pi (Figures 2B and 2C), indi-
cating that their membranes did not accumulate LC3. Despite
these results, we examined the potential role of various auto-
phagy proteins in aBCV formation via small interfering RNA
(siRNA)-mediated depletion in HeLa cells and first tested
whether their depletion affected Brucella trafficking to the ER.
Based on LAMP-1 exclusion during biogenesis of rBCVs (Celli
et al., 2003; Comerci et al., 2001; Salcedo et al., 2008; Starr
et al., 2008), single depletions of either the autophagy-elongation
proteins ATG5, ATG7, LC3B, or the autophagy-initiation proteins
Beclin1 or ULK1 (Figure S3A) did not affect eBCVmaturation into
rBCVs (Figure 3A), although they did prevent rapamycin-induced
LC3 lipid conjugation (Figure S3B). This demonstrates that
a functional autophagy pathway is not required for Brucella traf-
ficking to the ER. Depletion of either ULK1 or Beclin 1 signifi-
cantly decreased formation of aBCVs at 48 and 72 hr pi, and their
combined depletion nearly abolished aBCV formation (Figure 3B;
p < 0.05), despite unaffected intracellular bacterial proliferation
(Figures 3D and 3E). This indicates that aBCV formation requires
functional ULK1 and Beclin 1 autophagy-initiation/nucleationnc.
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knockdown of ATG5, ATG7, or LC3B did not impair, but instead
potentiated, aBCV formation (Figure 3C; p < 0.05), indicating
that, consistent with the lack of LC3 recruitment to aBCVs
(Figures 2B and 2C), canonical autophagy-elongation com-
plexes are not involved in aBCV formation. To confirm these
findings in macrophages, we depleted either Atg7 or Beclin 1
(Figures 3F–3H) and examined aBCV formation at 72 hr pi.
Compared to a nontargeting (siNT) control, Atg7 depletion did
not affect aBCV formation (Figures 3G and 3H), yet Beclin 1
depletion significantly reduced this process (Figures 3G and
3H). Hence, aBCV formation in macrophages also requires the
autophagy nucleation protein Beclin 1, but not the autophagy-
elongation protein Atg7.
aBCV Formation Is Independent of Autophagy-
Elongation Complexes
To exclude the possibility that the ATG5, ATG7, or LC3B inde-
pendence of aBCV formation results from residual activity due
to incomplete siRNA-mediated depletion, we examined aBCV
formation in various autophagy null mutation BMMs. Using either
Atg5flox/flox control mice or Atg5flox/flox-Lyz-Cre mice lacking
Atg5, Atg16L1flox/flox control mice or Atg16L1flox/flox-Lyz-Cre
mice lacking Atg16L1 or Atg4B/mice, we first tested whether
the absence of these proteins affected Brucella trafficking to the
ER. Consistent with our results in HeLa cells, the timing and
extent of eBCV to rBCV maturation was indistinguishable in
either control C57BL/6J, Atg5flox/flox control or Atg5flox/flox-Lyz-
Cre BMMs (Figures S4A and S4B), demonstrating that Brucella
trafficking to the ER is independent of Atg5. Similarly, Brucella
trafficking to the ER was unaffected in either Atg16L1flox/flox
control Atg16L1flox/flox-Lyz-Cre or Atg4B/ BMMs (Figure S4C),
confirming that Brucella trafficking to the ER is independent of
these autophagy proteins. Biogenesis of aBCVs was also not
impaired in the absence of either Atg5, Atg16L1, or Atg4B (Fig-
ures 4A and 4B), since aBCVs formed similarly in either control
(C57BL6/J, Atg5flox/flox, Atg16L1flox/flox) or deficient (Atg5flox/flox-
Lyz-Cre, Atg16L1flox/flox-Lyz-Cre, Atg4B/) BMMs, and was
even slightly more pronounced in the null mutation BMMs
(Figure 4B). Furthermore, ultrastructural analysis of aBCVs in
Atg5flox/flox-Lyz-Cre, Atg16L1flox/flox-Lyz-Cre and Atg4B/
BMMs showed aBCVs with closed double or multimembranes
at frequencies comparable to control BMMs (Figure 4A).
Complete formation of aBCVs in the absence of these auto-
phagy-elongation proteins in BMMs demonstrates that aBCV
formation is an Atg5-, Atg16L1-, and Atg4B-independent
process.
Altogether, aBCV formation in both macrophages and epithe-
loid cells depends upon the autophagy-associated proteins Be-
clin 1 and ULK1 but not the autophagy-elongation proteins
ATG5, ATG16L1, ATG7, ATG4B, and LC3B.
ER-LocalizedBeclin 1-ATG14LComplexes AreRequired
for aBCV Formation
Three Beclin 1-PI3-kinase complexes have been identified that
are compartmentalized and fulfill differential functions through
their association with the additional subunits ATG14L/Barkor,
Rubicon, and UVRAG (Itakura et al., 2008; Liang et al., 2008;
Matsunaga et al., 2009; Sun et al., 2008). The ATG14L-contain-Cell Hing complex localizes to the ER and is required for autophagy
initiation (Axe et al., 2008; Itakura et al., 2008; Itakura and Miz-
ushima, 2010; Matsunaga et al., 2009, 2010), while UVRAG-con-
taining complexes localize to Rab9-positive endocytic compart-
ments and modulate autophagosome maturation and endocytic
trafficking (Itakura et al., 2008; Liang et al., 2008; Matsunaga
et al., 2009; Thoresen et al., 2010; Zhong et al., 2009). Given
the ER nature of rBCVs and the requirement of Beclin 1 for the
progression of Brucella infection from rBCVs into aBCVs, we
tested whether the ER-localized Beclin 1 complex is required
for aBCV formation. First, treatment with the class III PI3-kinase
inhibitor 3-methyladenine (3-MA) or the PI3-kinase inhibitor
LY294002 for 14 hr, reduced aBCV formation by 50% and
75% in BMMs and HeLa cells, respectively (Figure 5A), indi-
cating that aBCV formation depends upon PI3-kinase activity.
Furthermore, aBCVs showed recruitment of a 2xFYVE-GFP
fusion protein in HeLa cells (Figure 5B), indicating PI3P genera-
tion at sites of aBCV biogenesis. Hence, PI3-kinase activity is
detectable at sites of aBCV formation and required for their
formation.
We next depleted either ATG14L or UVRAG in HeLa cells (Fig-
ure S3) to determine which Beclin 1 complex(es) are involved in
aBCV formation. Depletion of ATG14L, which prevents targeting
of the Beclin 1-VPS34-VPS15 autophagy complex to the ER
(Matsunaga et al., 2010), reduced aBCV formation by 45%
(Figure 5C), similar to the effect of Beclin 1 depletion (Figure 3B).
By contrast, depletion of UVRAG did not affect aBCV formation
(Figure 5C), indicating that the endocytic trafficking-associated
functions of Beclin 1 complexes do not contribute to aBCV
formation. Consistently, depletion of Rab9 also did not affect
aBCV formation (Figure S5). Altogether, this demonstrates that
the ER localized Beclin 1-PI3-kinase complex is engaged on
rBCVs to generate aBCVs, functionally linking the biogenesis
of these vacuoles to autophagy initiation.
aBCV Formation Completes the Brucella Intracellular
Cycle and Promotes Subsequent Infections
Given the late occurrence of aBCVs, we tested whether they
contribute to completing the bacterium’s infectious cycle, by
promoting bacterial egress and subsequent infections.
Secondary infection events were examined in HeLa cells, in
which isolated, infected cells could be monitored for their ability
to generate infection foci through subsequent bacterial invasion
of neighboring cells. HeLa cells left untreated (data not shown) or
treated with nontargeting siRNA (siNT; Figure 6C) showed that
50% ± 2.8% of highly infected cells generated infection foci by
72 hr pi (Figures 6C and 6D), indicating that infected cells release
infectious bacteria in their vicinity. Most (78% ± 1.9%) of these
infection foci were associated with aBCV-containing cells
(Figures 6A and 6B), correlating aBCV formation with reinfection
events. Consistent with aBCV biogenesis, the formation of infec-
tion foci was significantly reduced upon depletion of Beclin1,
ULK1, or both proteins (Figures 6C and 6D), but not upon deple-
tion of ATG5, ATG7, or LC3B (Figure 6D). This indicates that
aBCV formation promotes bacterial release and infection of
adjacent cells (Figure S6), but does not contribute to bacterial
proliferation (Figure 3E). Hence, aBCV formation allows for the
completion of the Brucella intracellular cycle and promotes
cell-to-cell spread.ost & Microbe 11, 33–45, January 19, 2012 ª2012 Elsevier Inc. 37
Figure 3. Role of Autophagy Proteins in Brucella Trafficking and aBCV Formation
(A) Quantification of LAMP-1-positive BCVs up to 24 hr in siRNA-depleted HeLa cells.
(B) Quantification of aBCV formation at 24, 48, and 72 hr pi in HeLa cells treated with nontargeting siRNA (siNT), siBeclin 1, siULK1, or siULK1 and siBeclin 1.
(C) Quantification of aBCV formation at 24, 48, and 72 hr pi in HeLa cells treated with nontargeting siRNA (siNT), siATG5, siLC3B, or siATG7. All data are shown as
means ± SD from three independent experiments.
(D) Representative confocal micrographs of HeLa cells treated with either nontargeting (siNT) or siULK1+siBeclin1 siRNAs, infected with DsRedm-expressing
B. abortus 2308 (red) and immunostained for LAMP-1 (green) and calnexin (blue) at 72 hr pi. Scale bars represent 10 and 2 mm.
(E) Representative intracellular growth curves ofB. abortus 2308 in HeLa cells treatedwith either nontargeting (siNT) or siULK1+siBeclin1 siRNAs. Data are shown
as means ± SEM from a representative experiment performed in triplicate.
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As a prominent player in intracellular innate immunity, autophagy
controls the fate of many intracellular microbes (Levine et al.,
2011) through xenophagic capture that involves the canonical,
ATG protein-dependent nucleation and elongation machineries
originally identified as actors of non selective bulk autophagic
degradation (Birmingham et al., 2006; Nakagawa et al., 2004;
Ogawa et al., 2005). Similarly, bacterial pathogens that may
benefit from autophagy, such as C. burnetii, Y. pestis, and
Y. pseudotuberculosis, seem to do so by also subverting
ATG5- and LC3-dependent processes (Gutierrez et al., 2005;
Moreau et al., 2010; Pujol et al., 2009). Hence, interactions of
pathogens with autophagy generally invoke ATG5- and LC3-
dependent autophagy machineries, with the exception of the
ATG5-independent capture of cytosolic M. marinum (Collins
et al., 2009). Here, we uncover a case of bacterial subversion
of ULK1-, Beclin 1-, and ATG14L-dependent, but ATG5-,
ATG4B-, ATG16L1-, ATG7-, and LC3B-independent, auto-
phagy-like membrane rearrangements that benefits the infection
process of the intracellular pathogen B. abortus.
Previous studies of the Brucella intracellular cycle in epithelial
cells have implicated autophagy in its trafficking to the ER
(Pizarro-Cerda´ et al., 1998a; Pizarro-Cerda´ et al., 1998b). It
was recently proposed that the UPR receptor IRE1a promotes
Brucella intracellular growth by inducing autophagosome forma-
tion at the ER, which in turn promotes BCV fusion with this
compartment (Qin et al., 2008). Yet, this model awaits experi-
mental confirmation and the initial evidence for autophagy-
dependent Brucella trafficking (Pizarro-Cerda´ et al., 1998a,
1998b) lacked the scrutiny of current methods that specifically
interrogate this pathway (Mizushima et al., 2010). By examining
Brucella trafficking to the ER using either macrophages carrying
various null mutations in ATG proteins or HeLa cells depleted of
an array of autophagy-associated proteins, we demonstrate
here that this bacterium does not require the autophagy proteins
ATG5, ATG7, ATG16L1, ATG4B, LC3B, Beclin 1, and ULK1 to
generate ER-derived rBCVs, nor does it recruit LC3 on BCVs
at any stage (data not shown), clearly ruling out a role for this
pathway in Brucella trafficking to the ER in both murine and
human cells. Instead, we show that that ULK1- and Beclin1-
dependent autophagy nucleation machineries contribute to
a post-ER replication stage of the Brucella life cycle, in which
bacteria generate aBCVs to complete their infectious cycle.
The formation of endosomal aBCVs from ER-derived rBCVs is
reminiscent of the maturation of Legionella pneumophila-con-
taining vacuoles into acidic, endocytic organelles (Sturgill-Kos-
zycki and Swanson, 2000), since this bacterium also proliferates
within ER-derived vacuoles (Swanson and Isberg, 1995). This
suggests that pathogens exploiting the secretory pathway may(F) Representative western blot analysis of Atg7 and Beclin1 depletion at 0 and 7
Actin was used as a loading control.
(G) Quantification of aBCV formation at 72 hr pi in BMMs treated with nontargeting
independent experiments.
(H) Representative confocal micrographs of C57BL/6J BMMs treated with nonta
B. abortus 2308 (red) and immunostained for LAMP-1 (green) and calnexin (blue
Asterisks denote statistically significant differences (two-tailed Student’s t test; p
Cell Htake advantage of common membrane rearrangements exem-
plified by aBCV biogenesis to (re-)enter the endosomal compart-
ment and complete their infectious cycle.
The reliance of aBCV formation on nucleation but not elonga-
tion complexes indicates thatBrucella either partially co-opts the
canonical autophagic pathway and uses yet to be uncovered
membrane rearrangements to complete rBCV to aBCV conver-
sion, or subverts an autophagic process that is independent of
the canonical elongation complexes. Interestingly, depletion of
ATG5, ATG7, or LC3B enhanced aBCV formation in HeLa cells,
as did null mutations in Atg5, Atg16L1, and Atg4B in BMMs,
arguing that autophagy-elongation complexes functionally
compete with the mechanisms of aBCV formation, possibly
along an alternative pathway. Indeed, Nishida et al. recently re-
ported an ATG5/ATG7-independent alternative autophagy-like
process that, similarly to aBCV formation, required Beclin 1
and ULK1 and was not associated with LC3 recruitment (Nishida
et al., 2009). However, this pathway also depends upon the small
GTPase Rab9 (Nishida et al., 2009), yet aBCV formation did not
require Rab9 in HeLa cells. Hence, we propose that ER-localized
brucellae engage membrane rearrangements dependent upon
a subset of autophagy-associated proteins, that may contribute
to unconventional xenophagic responses at the ER and possibly
other yet to be identified autophagy-related host processes.
The signals that initiate aBCV formation remain to be charac-
terized. Although ER stress can induce autophagy via the UPR
(Bernales et al., 2006; Ogata et al., 2006), Brucella infection
was not associated with induction of the UPR (data not shown),
suggesting this pathway is not triggered upon Brucella prolifera-
tion in the ER, or is bacterially inhibited, and probably does not
account for aBCV formation. It remains to be determined
whether the requirement for ULK1 in aBCV formation links this
process to nutrient availability via mTOR (Levine et al., 2011),
or whether the ULK1 complex is activated upon different, infec-
tion-related signals and detection of pathogen-associated
molecular patterns (PAMPs). The strong association of aBCVs
with infection foci indicates that these late vacuoles contribute
to bacterial release, either by promoting an exocytic process
or through cell death and bacterial egress. While the hypothesis
of an exocytic egress requires additional investigation, we did
not detect any significant cell death in the Brucella infected cell
populations concomitant with aBCV formation (data not shown),
consistent with the reported ability of Brucella to prevent pro-
grammed cell death in monocytes and epithelial cells (Ferrero
et al., 2009; Gross et al., 2000).While future studies should clarify
themechanisms of bacterial release and reinfection, our findings
advance our understanding of Brucella intracellular pathogen-
esis and demonstrate a case of selective subversion of auto-
phagy-associated machineries to the benefit of a bacterial
cellular infection process.2 hr pi in BMMs treated with nontargeting siRNAs (siNT), siBeclin1, or siATG7.
siRNAs (siNT), siAtg7, or siBeclin1. Data are shown as means ± SD from three
rgeting (siNT), siAtg7, or siBeclin1 siRNAs, infected with DsRedm-expressing
) at 72 hr pi. Scale bars represent 10 and 2 mm.
< 0.05). See also Figure S3.
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Figure 4. Atg5, Atg16L1, and Atg4B Are Not Required for aBCV Formation
(A) Representative fluorescence confocal and TEM images of C57BL/6J, Atg5flox/flox, Atg5flox/flox-Lyz-Cre, Atg16L1flox/flox, Atg16L1flox/flox-Lyz-Cre, and Atg4B/
BMMs infected with either B. abortus 2308 (TEM) or DsRedm-expressing B. abortus 2308 (red) and immunostained for LAMP-1 (green) and calreticulin (blue) at
72 hr pi. Scale bars represent 10 and 2 mm (immunofluorescence) or 500 nm (TEM). Values on electron micrographs represent the percentage of bacteria
contained within multimembrane BCVs and the number of bacteria analyzed from two independent experiments.
(B) Quantification of LAMP-1-positive BCVs (aBCVs) formation in C57BL/6J, Atg5flox/flox, Atg5flox/flox-Lyz-Cre, Atg16L1flox/flox, Atg16L1flox/flox-Lyz-Cre, and
Atg4B/ BMMs infected with DsRedm-expressing B. abortus 2308 for 72 hr. Data are shown as means ± SD from three independent experiments.
See also Figure S4.
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Bacterial Strains and Plasmids
The bacterial strains used in this study were the smooth virulent Brucella
abortus strain 2308 and two derivatives expressing either the monomeric
red fluorescent protein DsRedm from plasmid pJC44 (Starr et al., 2008) or
the green fluorescent protein GFP under the control of the tetracycline-40 Cell Host & Microbe 11, 33–45, January 19, 2012 ª2012 Elsevier Iinducible promoter tetA from Tn10 on plasmid pJC45 (see the Supplemental
Experimental Procedures). All bacteria were grown in tryptic soy broth (TSB;
Sigma) or on TS agar plates (TSA; Sigma) supplemented with kanamycin
(50 mg/ml) to select the pBBR1-MCS2 derivatives pJC44 and pJC45. For
infection of eukaryotic cells, 2 ml TSB was inoculated with a few bacterial
colonies from a freshly streaked TSA plate and grown at 37C to early
stationary phase.nc.
Figure 5. aBCV Formation Requires PI3-Kinase Activity and the Beclin1-ATG14L Complex
(A) Quantification of aBCV formation in either Brucella-infected BMMs (top) or HeLa cells (bottom) that were treated with carrier controls (H2O or DMSO), 3-MA
(10 mM), or LY294002 (50 mM) for 14 hr prior to analysis at 72 hr pi. Data are shown as means ± SD from three independent experiments.
(B) Representative confocalmicrograph of a HeLa cell expressing thePI3P probe, 2xFYVE-GFP (green), that was infectedwith DsRedm-expressingB. abortus 2308
(red) for 72hrpi andprocessed forLAMP-1 immunostaining (blue). Insets aremagnificationsof theboxedareason themain image.Scale bars represent 10and2mm.
(C) Representative confocal micrographs of HeLa cells treated with nontargeting (siNT), siATG14L, or siUVRAG siRNAs that were infected with DsRedm-
expressing B. abortus 2308 (red) for 72 hr pi and processed for LAMP-1 immunostaining (blue). Quantification of aBCV formation (middle) in HeLa cells treated
with nontargeting (siNT), siATG14L, or siUVRAG siRNAs and infected with DsRedm-expressing B. abortus 2308 (red) for 24, 48 or 72 hr is shown. Data are shown
as means ± SD from three independent experiments. Asterisks denote statistically significant differences (two-tailed Student’s t test; p < 0.05).
See also Figure S5.
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Figure 6. aBCV Formation Promotes Reinfection Events
(A) Representative confocal micrographs of HeLa cells infected with DsRedm-expressing B. abortus 2308, incubated under reinfection-permissive conditions for
24 hr before analysis at 72 hr pi, and immunostained for LAMP-1 to detect aBCVs. Asterisks denote reinfected cells neighboring a primary infected cell containing
aBCVs (left). Infected cells that do not contain aBCVs (right) are not associated with infection foci. Bacteria are shown in red, LAMP-1 is pseudocolored in white,
and DNA is shown in blue.
(B) Association of aBCV-containing cells with infection foci. Infection foci were examined for their association with aBCV-containing cells at 72 hr pi. Data are
shown as means ± SD from three independent experiments.
(C) Representative confocal micrographs of HeLa cells treated with either nontargeting (siNT; left) or siULK1+siBeclin1 siRNA (right) infected with DsRedm-
expressing B. abortus 2308 (pseudocolored in white), incubated under reinfection-permissive conditions for 24 hr before analysis at 72 hr pi and stained for DAPI
(shown in blue). Asterisks denote reinfected cells. Scale bars represent 20 mm.
(D) Quantification of infection foci at 72 hr pi in HeLa cells treated with nontargeting (siNT), siATG5, siATG7, siLC3B, siBeclin1, siULK1, or siULK1+siBeclin1
siRNAs. Data are shown as means ± SD from three independent experiments. Asterisk denotes a statistically significant difference from the siNT control (two-
tailed Student’s t test; p < 0.05).
See also Figure S6.
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Antibodies used for immunofluorescence microscopy were as follows: rat
anti-mouse LAMP-1 (clone 1D4B, developed by J.T. August and obtained
from the Developmental Studies Hybridoma Bank [DSHB] developed under
the auspices of the National Institute of Child Health and Human Development
and maintained by The University of Iowa, Department of Biological Sciences,
Iowa City, IA), mouse anti-human LAMP-1 (clone H4A3, DSHB), rabbit mono-
clonal anti-Rab7 (clone D95F2, Cell Signaling Technology, Boston, MA),
mouse anti-LC3A/B (Clone 4E12; Medical and Biological Laboratories
[MBL], Japan), rabbit polyclonal anti-LC3A/B/C (MBL), rabbit polyclonal
anti-calnexin (Assay Designs, Ann Arbor, MI), rabbit polyclonal anti-calreticu-
lin (Affinity BioReagents, Golden, CO), and Alexa Fluor 488-donkey
anti-mouse, anti-rat, or Cyanin 5-conjugated goat anti-rabbit, anti-mouse
(Jackson ImmunoResearch Laboratories, West Grove, PA). Rabbit polyclonal
anti-actin (Bethyl Laboratories, Montogomery, TX), mouse monoclonal anti-42 Cell Host & Microbe 11, 33–45, January 19, 2012 ª2012 Elsevier IGAPDH (Affinity Bioreagents, Rockford, IL), rabbit polyclonal anti-ATG5
(Cell Signaling Technology), rabbit anti-ULK1(R600) (Cell Signaling Tech-
nology), rabbit anti-LC3B(D11)XP (Cell Signaling Technology), rabbit anti-
ATG7 (Cell Signaling Technology), mouse monoclonal anti-Beclin1 (Abgent,
San Diego, CA), rabbit anti-ATG14L (MBL), rabbit anti-UVRAG (Matsunaga
et al., 2009), and HRP-conjugated anti-rabbit IgG or anti-mouse IgG
(1:10,000, Cell Signaling Technology) were used for western blotting.
DAPI and propidium iodide (Invitrogen, Carlsbad, CA) were used as DNA
stains. siRNA-mediated knockdown of mammalian proteins was performed
using ON-TARGETplus SMARTpool siRNA (Thermo Fisher Scientific, Lafay-
ette, CO) and ON-TARGETplus Non-Targeting Pool siRNA (D-001810) as con-
trol. siRNA against human proteins included ATG5 (L-004374), LC3B
(L-012846), ATG7 (L-020112), Beclin1 (L-010552), ULK1 (L-005049),
ATG14L (KIAA0831, L-020438), and UVRAG (L-015465), and mouse proteins
included Atg7 (L-049953) and Beclin1 (L-055895).nc.
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BMMs from C57BL/6J (Jackson Laboratories, Bar Harbor, ME), Atg5flox/flox
and Atg5flox/flox-lyz-Cre (Zhao et al., 2008), Atg16L1flox/flox and Atg16L1flox/flox-
lyz-Cre (H.W.V. and S.H., unpublished data), or Atg4B/ mice (Marin˜o et al.,
2010) were harvested according to procedures approved by the Rocky Moun-
tain Laboratories Animal Care and Use Committee and processed as
described (Chong et al., 2008). HeLa cells (ATCC clone CCL-2) were cultured
as described (Starr et al., 2008). For infections, cells were seeded either on
12 mm glass coverslips in 24-well plates (for microscopy; 5 3 104/well) or
6-well plates (for western blot analysis; 1.53 105/well) 24 to 48 hr prior to infec-
tion. Infections were performed as described (Starr et al., 2008), except that
cells were maintained in gentamicin-free medium until 24 hr, then afterwards
in medium containing 25 mg/ml gentamicin to prevent reinfection events,
unless specified otherwise. In reinfection experiments, gentamicin was
removed at 48 hr pi from infected HeLa cells and samples processed at
72 hr pi and analyzed for infection foci. These were defined as a cell containing
high numbers of bacteria (primary infection) surrounded by at least four adja-
cent cells containing few bacteria (secondary infection). For inhibition of PI3-
kinase activity, BMMs and HeLa cells were incubated with 3-methyladenine
(3-MA) (Sigma, St. Louis, MO; 10mM) or LY294002 (Cell Signaling Technology;
50 mM) for 16 hr prior to analysis, without any detectable cytotoxicity. For
labeling of acidic compartments, BMMs were incubated in presence of
50 nM LysoTracker Red DND-99 (Invitrogen) for 1 hr prior to analysis. For
labeling of the endocytic compartment, BMMs were incubated in presence
of 50 mg/ml Alexa Fluor 568-conjugated dextran (MW10,000; Invitrogen) for
2 hr and immediately analyzed by confocal live-cell imaging. For evaluation
of intracellular growth, the number of viable intracellular bacteria per well
was determined for each time point through enumeration of colony forming
units (CFUs) as described (Starr et al., 2008).
Transfections and siRNA-Mediated Depletion of Host Proteins
A plasmid expressing 2xFYVE-EGFP (pEGFP-2xFYVE, a gift from George
Banting [Pattni et al., 2001]) was transfected in HeLa cells 1 day prior to infec-
tion using FuGene6 transfection reagent (Roche) according to the manufac-
turer’s instructions. For siRNA-mediated depletion, HeLa cells were trans-
fected 24 hr prior to infection using DharmaFECT1 Transfection Reagent
(Dharmacon) with 30–100 nM siRNA. BMMs (1.53 106 cells) were transfected
via nucleofection with 2 mM of siRNA using the Amaxa Biosystems Mouse
Macrophage Nucleofector kit (Lonza, Basel, Switzerland) and a Nucleofector
II electroporator (program Y-001) 16 hr prior to infection. After nucleofection,
cells were plated at 5 3 104 cells/well (24-well plate) or 4 3 105 cells/well
(12-well plate). Protein depletion was verified at times equivalent to 0 and
72 hr pi by western blotting and densitometry analysis with a Kodak Image
Station 4000MM PRO (Eastmann Kodak, Rochester NY).
Microscopy
For immunofluorescence microscopy, infected cells were processed as
described (Starr et al., 2008), and samples were observed on a Carl Zeiss
AxioImager epi-fluorescence microscope equipped with a Plan Apo
633/1.4 objective for quantitative analysis or a Carl Zeiss LSM 710 confocal
laser scanning microscope for image acquisition (Carl Zeiss Micro Imaging,
Thornwood, NY). Confocal images of 1024 3 1024 pixels were acquired with
the Carl Zeiss ZEN 2008 software and assembled with Adobe Photoshop
CS3 (Adobe Systems, San Jose, CA). Live-cell imaging analysis was per-
formed on a Carl Zeiss MicroImaging LSM 5 LIVE confocal laser scanning
microscope equipped with a LCI Plan 633/1.45 NA objective. Images
(768 3 768 pixels) were acquired with 488 nm and 561 nm solid-state lasers
for sequential excitation and the Carl Zeiss ZEN 2008 software and were
assembled in Adobe Photoshop CS3. Transmission electron microscopy
(TEM) was performed as described in the Supplemental Experimental
Procedures.
Western Blot Analysis
Samples were normalized to total protein concentrations, resolved on SDS-
PAGE and transferred to Hybond-ECL nitrocellulose membranes (Amersham
Biosciences) as described previously (Chong et al., 2008). Total protein
concentration was determined using a BCA protein Assay Kit (Pierce).Cell HStatistical Analysis
A Student’s t test was used to assess statistical differences between two
experimental data sets, while multiple comparisons were performed with
a one-way ANOVA followed by a Tukey’s test. All values shown, unless other-
wise stated, are the mean values ± the SD from three independent
experiments.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at doi:10.1016/j.
chom.2011.12.002.
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